Cargando…
Harnessing immunomodulation during DNA damage in Ewing sarcoma
Ewing sarcoma is a fusion-oncoprotein-driven primary bone tumor most commonly diagnosed in adolescents. Given the continued poor outcomes for patients with metastatic and relapsed Ewing sarcoma, testing innovative therapeutic approaches is essential. Ewing sarcoma has been categorized as a ‘BRCAness...
Autores principales: | Daley, Jessica D., Olson, Adam C., Bailey, Kelly M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722957/ https://www.ncbi.nlm.nih.gov/pubmed/36483025 http://dx.doi.org/10.3389/fonc.2022.1048705 |
Ejemplares similares
-
MicroRNAs in Ewing Sarcoma
por: Dylla, Layne, et al.
Publicado: (2013) -
Extraosseus Ewing's Sarcoma of the Forearm
por: Bansal, Kuldeep, et al.
Publicado: (2020) -
Editorial: Harnessing DNA Damage Response in Gynecologic Malignancies
por: Tse, Ka Yu, et al.
Publicado: (2022) -
Successful Treatment of Patient With Ewing Sarcoma in the Setting of Inherited Cholestatic Liver Disease
por: Daley, Jessica, et al.
Publicado: (2023) -
A rare case of Ewing's sarcoma of the kidney
por: Alghamdi, Mohammed Hasen A., et al.
Publicado: (2019)